Marc Antoine Aimé | Regen Lab

BeNeLux Partnership

par Marc Antoine Aimé | Fév 10, 2025 | Corporate

Regenerative Medicine Expansion in the BeNeLux Region We are pleased to announce an exciting development for Regen Lab in the BeNeLux region. To enhance our presence and ensure optimal service, we have established a new distribution network in collaboration with...

RegenPRP™ : Androgenetic alopecia | Ho A, Sukhdeo K, Lo Sicco K, Shapiro J.

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Alopecia

Androgenetic alopecia Ho A, Sukhdeo K, Lo Sicco K, Shapiro J. Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy. OBJECTIVE Evaluate the efficacy and safety of RegenPRP™ mesotherapy in combination with other...

RegenPRP™ + ATS : Chronic Wounds | Kontopodis, N., et al. | Rainys, D., et al.

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Wound Care

Chronic Wounds : 1 Diabetic Foot Ulcers | 2 Leg ulcers 1 Kontopodis, N., et al. | 2 Rainys, D., et al. Diabetic Foot Ulcers (DFU) Effectiveness of RegenPRP® fibrin clot to enhance healing of DFU in patients with concomitant peripheral arterial disease (PAD) and...

RegenPRP™ : Achilles tendinopathies | Salini 2015

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Tendinopathies

Achilles tendinopathies Salini 2015 Platelet Rich Plasma Therapy in Non-insertional Achilles Tendinopathy: The Eicacy is Reduced in 60-years Old People Compared to Young and Middle-Age Individuals. OBJECTIVE Evaluate the use of RegenPRP™ for the treatment of...

REGENPRP™-HA COMBINATION : Facial appearance | Hersant B. et al | Micheels P.

par Marc Antoine Aimé | Jan 28, 2025 | Clinical Study Dermal PRP-HA

REGENPRP™-HA COMBINATION : Facial appearance Hersant B. et al | Micheels P. A significant breakthrough in facial rejuvenation has been highlighted in a prospective study published in the Journal of the American Academy of Dermatology in 2017. Conducted by Hersant et...

« Entrées précédentes

Entrées suivantes »



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



Hyaluronic Acid

Coming Soon



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.